MetLife (NYSE:MET) Downgraded to “Hold” Rating by StockNews.com

MetLife (NYSE:METGet Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

Several other research analysts also recently weighed in on MET. Barclays cut their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Thursday, October 31st. TD Cowen increased their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Jefferies Financial Group increased their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Finally, Wells Fargo & Company boosted their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.62.

Get Our Latest Research Report on MetLife

MetLife Stock Performance

NYSE:MET opened at $82.25 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market cap of $56.95 billion, a PE ratio of 16.58, a P/E/G ratio of 0.76 and a beta of 1.06. The firm has a 50 day simple moving average of $83.30 and a 200-day simple moving average of $77.94. MetLife has a 1-year low of $64.61 and a 1-year high of $89.05.

Hedge Funds Weigh In On MetLife

Hedge funds and other institutional investors have recently made changes to their positions in the business. MeadowBrook Investment Advisors LLC lifted its stake in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. grew its stake in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. acquired a new position in MetLife during the 3rd quarter worth approximately $30,000. Finally, Fortitude Family Office LLC boosted its holdings in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Company Profile

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.